Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

uniQure and CSL have become the first pharma companies to get regulatory approval for a gene therapy for haemophilia B anywhere in the world, after the FDA cleared their Hemgenix therapy for adults ...

Bad deals, nasty numbers, big mistakes and the occasional triumph. It’s been one heck of a year for corporate Australia.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...